Alcohol-induced bone disease: impact of ethanol on osteoblast proliferation.
The habitual consumption of even moderate quantities of alcohol (1 to 2 drinks/day) is clearly linked with reduced bone mass (osteopenia). Biochemical and histological evaluation of patients with alcoholic bone disease reveal a marked impairment in bone formation in the face of relatively normal bone resorption. Experiments using well-defined osteoblastic model systems indicate that the observed reductions in bone formation result from a direct, antiproliferative effect of ethanol on the osteoblast itself. As bone remodeling and mineralization are dependent on osteoblasts, it follows that the deleterious effect of alcohol on these cells would result in slowed bone formation, aberrant remodeling of skeletal tissue and, ultimately, osteopenia and fractures. The skeletal consequences of alcohol intake during adolescence, when the rapid skeletal growth ultimately responsible for achieving peak bone mass is occurring, may be especially harmful. The specific subcellular mechanisms whereby ethanol inhibits cell proliferation are, as yet, unknown. During the last few years, attention has shifted from nonspecific membrane perturbation effects to actions on certain signaling proteins. Specifically, there is increasing evidence that ethanol may exert significant effects on transmembrane signal transduction processes that constitute major branches of cellular control mechanisms. At present, abstinence is the only effective therapy for alcohol-induced bone disease. An improved understanding of the pathogenesis of alcohol-induced bone disease may eventually result in alternative therapeutic avenues for those who are unable to abstain.
Klein
R F
RF
Bone and Mineral Research Unit, Veterans Affairs Medical Center, Portland, OR 97207, USA.
D000428:Alcohol Drinking / Q000009:adverse effects* / Q000503:physiopathology; D000818:Animals; D001851:Bone Diseases, Metabolic / Q000209:etiology* / Q000503:physiopathology; D016723:Bone Remodeling / Q000187:drug effects / Q000502:physiology; D002455:Cell Division / Q000187:drug effects* / Q000502:physiology; D002460:Cell Line; D000431:Ethanol / Q000009:adverse effects*; D006801:Humans; D010006:Osteoblasts / Q000187:drug effects* / Q000502:physiology; D010024:Osteoporosis / Q000209:etiology* / Q000503:physiopathology; D015398:Signal Transduction / Q000187:drug effects / Q000502:physiology
D000431:Ethanol